Autologous Transplantation

Autologous BMT uses the patient’s own haematopoietic progenitor cells.

The cells are usually harvested from the peripheral blood following either a combination of chemotherapy and growth factors (Granulocyte Colony-Stimulating Factor, G-CSF), or G-CSF alone. High dose chemotherapy or chemotherapy in conjunction with radiotherapy is given to eradicate the underlying disease, and the stem cells are then reinfused to repopulate the patient’s bone marrow.